Billiontoone vs Fulgent Genetics
Billiontoone and Fulgent Genetics are similar in size: $305m and $323m of revenue in their latest fiscal years. Billiontoone grew faster (100.0% against 13.8%). Billiontoone kept more of each dollar of sales as profit: a net margin of 2.4% against -18.8%. Fulgent Genetics carries less debt relative to equity (0.2% against 11.9%).
| Latest fiscal year | BilliontooneBLLN, 2025 | Fulgent GeneticsFLGT, 2025 |
|---|---|---|
| Revenue | $305m | $323m |
| Revenue growth | 100.0% | 13.8% |
| Net income | $7.5m | −$60.5m |
| Operating margin | 5.3% | -28.2% |
| Net margin | 2.4% | -18.8% |
| Return on equity | 6.5% | -5.4% |
| Free cash flow | $15.7m | −$124m |
| Cash | $496m | $50.2m |
| Total debt | $57.2m | $2.4m |
| Debt to equity | 11.9% | 0.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $0 | $10.9m |
| Employees | 713 | — |
| Market value | $6.03bn | $531m |
| Price vs our value range | — | — |
| Moat score | — | 23 (Weak) |
| Insider trades, 12 months | 11 buys, 169 sales | 0 buys, 15 sales |